• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

MintNeuro: Venture Capital Funding History

MintNeuro

To add a bio or update company history, please click update information.

News from MintNeuro

    MintNeuro lands a £4m seed round led by Odyssey Ventures for semiconductor chips that connect devices directly with the brainMintNeuro lands a £4m seed round led by Odyssey Ventures for semiconductor chips that connect devices directly with the brain
    MintNeuro
    7 Oct 2026

    MintNeuro lands a £4m seed round led by Odyssey Ventures for semiconductor chips that connect devices directly with the brain

    MintNeuro develops specialised semiconductor chips that are purpose-built to operate inside the human body and connect devices with the brain and nervous system. MintNeuro enables developers of neural implants and other medical devices to avoid trade-offs between generic components and lengthy custom chip development.

    Imperial spinout MintNeuro raises £1m to advance neural implants with semiconductor technologyImperial spinout MintNeuro raises £1m to advance neural implants with semiconductor technology
    MintNeuro
    12 Nov 2024

    Imperial spinout MintNeuro raises £1m to advance neural implants with semiconductor technology

    MintNeuro develops compact semiconductor-based neural implants that reduce the invasiveness and power demands of traditional devices, supporting scalable neuromodulation treatments for conditions including epilepsy, Parkinson’s and dementia.

MintNeuro
  • Life Sciences
  • London, United Kingdom
  • £5m
  • mintneuro.com
  • Update Information

More venture news

  • Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases
    Oyster Therapeutics
    13 Nov 2026

    Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases

    Series ALife Sciences
  • Neobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours
    Neobe Therapeutics
    10 Nov 2026

    Neobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours

    SeedLife Sciences
  • PhaSER Biomedical secures a £2m grant from Gates Foundation to discover new treatments for neglected diseases
    PhaSER Biomedical
    9 Nov 2026

    PhaSER Biomedical secures a £2m grant from Gates Foundation to discover new treatments for neglected diseases

    GrantLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn